Virios Therapeutics Inc VIRI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:53 AM EDT
4.22quote price arrow down-0.01 (-0.24%)
Volume
2,631
52 week range
3.30 - 7.21
Loading...
  • Open4.37
  • Day High4.37
  • Day Low4.22
  • Prev Close4.23
  • 52 Week High7.21
  • 52 Week High Date01/20/22
  • 52 Week Low3.30
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap35.15M
  • Shares Out8.33M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.5

KEY STATS

  • Open4.37
  • Day High4.37
  • Day Low4.22
  • Prev Close4.23
  • 52 Week High7.21
  • 52 Week High Date01/20/22
  • 52 Week Low3.30
  • 52 Week Low Date05/11/22
  • Market Cap35.15M
  • Shares Out8.33M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.5

RATIOS/PROFITABILITY

  • EPS (TTM)-2.02
  • P/E (TTM)-2.08
  • Fwd P/E (NTM)-2.24
  • EBITDA (TTM)-16.545M
  • ROE (TTM)-89.28%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/12/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Virios Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Virios Therapeutics, Inc., formerly Virios Therapeutics, LLC., is a development-stage biotechnology company focused on advancing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM). Its lead development candidate is IMC-1, which is a fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination antiviral therapy designed to synergistically suppress Herpes Simplex Virus-1 (HSV-1)...
Address
44 Milton Avenue
Alpharetta, GA
30009
United States

Top Peers

SYMBOLLASTCHG%CHG
ALRN
Aileron Therapeutics Inc
0.2399-0.0201-7.7308%
ELEV
Elevation Oncology Inc
1.44+0.04+2.86%
RGLS
Regulus Therapeutics Inc
2.06-0.01-0.48%
LRMR
Larimar Therapeutics Inc
2.23+0.27+13.78%
ONCR
Oncorus Inc
1.31+0.05+3.97%